欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/H/1852/006
药品名称
Lapozan 5 mg Schmelztabletten
活性成分
olanzapine 5.0 mg
剂型
Orodispersible tablet
上市许可持有人
Medochemie Ltd. P.O.Box 51409 3505 Limassol Cyprus
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
许可日期
2009/08/31
最近更新日期
2021/10/08
药物ATC编码
N05AH03 olanzapine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
DE1852_Lapozan_spc-tabs-clean_20140924_renewal
Date of last change:2018/07/11
Final SPC
|
DE1852_Lapozan_spc-oro-clean_20140924_renewal
Date of last change:2018/07/11
Final Labelling
|
DE1852_Lapozan_labelling-oro-clean_20140924_renewal
Date of last change:2018/07/11
Final Labelling
|
DE1852_Lapozan_labelling-tabs-clean_20140924_renewal
Date of last change:2018/07/11
Final PL
|
DE1852_Lapozan_pil-oro-clean_20140924_renewal
Date of last change:2018/07/11
Final PL
|
DE1852_Lapozan_pil-tabs-clean_20140924_renewal
Date of last change:2018/07/11
PAR
|
PAREN-DE1852-Olanzapin-20100310-final
Date of last change:2013/06/10
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase